Lv11
28 积分 2025-08-31 加入
Comparative Effectiveness of SGLT2 Inhibitor and GLP-1 Receptor Agonist on Kidney and Cardiovascular Outcomes by Kidney Failure Risk
36分钟前
已完结
Cardiovascular Risk Across Different Glomerular Diseases
44分钟前
已完结
Anti-obinutuzumab antibodies in primary membranous nephropathy
22天前
已完结
The spectrum of biopsy-proven kidney diseases in elderly Chinese patients
1个月前
已完结
Clinical and pathological features of idiopathic membranous nephropathy in young people
1个月前
已完结
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS)
1个月前
已完结
Idiopathic membranous nephropathy in the elderly
1个月前
已完结
Treatment and clinical outcomes of elderly idiopathic membranous nephropathy: A multicenter cohort study in Korea
1个月前
已完结
Idiopathic membranous nephropathy in the elderly: A comparative study
1个月前
已完结
Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy
5个月前
已完结
皖公网安备34019202002308
